Αποτελέσματα Αναζήτησης
The use of testosterone replacement therapy in obese men with low testosterone levels has been controversial. This review aims to analyze the effectiveness of testosterone therapy for weight loss and preventing cardiovascular complications in obese men with low testosterone levels.
7 Οκτ 2016 · We conducted a randomised clinical trial in obese men with low to low-normal total testosterone to test the hypothesis that, following diet-induced loss of fat mass, testosterone treatment will prevent fat regain but maintain lean mass.
3 Δεκ 2021 · Objective: This systematic review evaluated the effect of testosterone replacement therapy (TRT) in men with obesity having low testosterone levels (LTLs). Design and methods: Search strategies were performed in MEDLINE, Embase, LILACS, and CENTRAL databases.
9 Οκτ 2020 · The aim of this review is to summarize evidence regarding the need for sex-specific interventions to treat obesity in men, focusing on the link between obesity and testosterone deficiency (TD) and the clinical utility of long-term testosterone therapy (TTh) as a treatment for obesity in men.
A study presented at ENDO 2019 showed that men with hypogonadism and obesity lost weight and were able to keep the weight off long-term. Testosterone treatment not only reduced weight, but also the risk for mortality and major adverse cardiovascular events.
The purpose of this article is to examine the contemporary data linking testosterone therapy in overweight and obese men with testosterone deficiency to increased lean body mass, decreased fat mass, improvement in overall body composition and sustained weight loss.
Testosterone replacement therapy demonstrates beneficial effects on measures of obesity that are partially explained by both direct metabolic actions on adipose and muscle and also potentially by increasing motivation, vigour and energy allowing obese individuals to engage in more active lifestyles.
